UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to __________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) North Carolina 47-3414576 State or Oth ...

cbdMD, Inc. (NYSE:YCBD) Q3 2021 Results Earnings Conference Call August 12, 2021 4:15 PM ET Company Participants Ronan Kennedy - CFO, COO, Secretary & Treasurer Martin Sumichrast - Chairman & Co-CEO Conference Call Participants Operator Good afternoon. Welcome to cbdMD, Incorporated's June 30, 2021 Third Quarter Fiscal 2021 Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its third quarter fiscal 2021 results, which followed the filing of its quarterl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to _______________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) North Carolina 47-341 ...

Financial Data and Key Metrics Changes - Total net sales for Q2 fiscal 2021 reached an all-time high of $11.8 million, representing a 26% year-over-year increase and a seasonal sequential dip of 4% [26] - For the six months ending March 2021, total sales were $24.1 million, a 24% increase compared to $19.5 million in the same period last fiscal year [27] - GAAP gross profit margin was 69% for Q2 fiscal 2021, compared to 71% for the same period last year [32] - GAAP loss from operations was approximately $4.1 million for Q2 fiscal 2021, an improvement from a $5.6 million loss in the prior year period [34] Business Line Data and Key Metrics Changes - E-commerce sales for Q2 fiscal 2021 were $8.4 million, a 23% year-over-year increase, representing approximately 71% of total net sales [27] - Wholesale business generated $3.4 million in net sales for Q2 fiscal 2021, compared to $2.6 million in the same quarter of fiscal 2020 [29] - Demand for Paw CBD was strong, and the initial release of cbdMD Botanicals was well received [31] Market Data and Key Metrics Changes - The company has sold products in over 31 countries and is expanding its presence internationally [16] - The U.K. and European Union markets present significant opportunities, with applications filed for regulatory compliance [16][17] Company Strategy and Development Direction - The company aims to be the leading global CBD consumer brand, focusing on new product launches, partnerships, and international market expansion [9] - A new subsidiary, cbdMD Therapeutics, was formed to explore therapeutic applications of CBD [22] - The company is committed to quality and operational excellence, pursuing additional certifications [48] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about substantial net sales growth based on new product launches and market expansion [9] - The company anticipates maintaining gross profit margins between 65% and 70% [32] - Management highlighted the importance of brand equity and quality products in driving future growth [19] Other Important Information - The company had cash and cash equivalents of approximately $23.7 million as of March 31, 2021, up from $14.8 million as of September 30, 2020 [44] - The implementation of a new ERP system aims to improve operational efficiency and data visibility [47] Q&A Session Summary - No questions were raised during the Q&A session, and the conference call concluded without further inquiries [50][51]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) Registrant's Telephone Number, ...

cbdMD, Inc. (NYSE:YCBD) Q1 2021 Earnings Conference Call February 9, 2021 4:15 PM ET Company Representatives Marty Sumichrast - Chairman, Co-CEO Ronan Kennedy - Chief Financial Officer Ken Cohn - Chief Marketing Officer Conference Call Participants Scott Fortune - Roth Capital Partners Operator Good afternoon. Welcome to the cbdMD Inc. December 31, 2020, First Quarter Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its first quarter fiscal 2021 resul ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number 001-38299 cbdMD, INC. (Exact name of registrant as specified in its charter) North Carolina 47-3414576 (S ...

cbdMD, Inc. (NYSE:YCBD) Q4 2020 Earnings Conference Call December 22, 2020 4:15 PM ET Company Participants Ronan Kennedy - CFO Marty Sumichrast - Chairman and Co-CEO Ken Cohn - Chief Marketing Officer Conference Call Participants Paul Cooney - Joseph Gunnar Michael Galantino - Chapin Davis Barry Mendel - Mendel Money Management Operator Good afternoon. Welcome to the cbdMD Incorporated Fourth Quarter and Fiscal Year Ended September 30, 2020 Earnings Call and Update. This afternoon, the company issued a pres ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-38299 CBDMD, INC. (Exact name of registrant as specified in its charter) North Carolina 47-3414576 (State ...

cbdMD, Inc. (NYSE:YCBD) Q3 2020 Results Earnings Conference Call August 12, 2020 4:15 PM ET Company Participants Mark Elliott - CFO and COO Marty Sumichrast - Chairman and Co CEO Ken Cohn - Chief Marketing Officer Lance Blundell - General Counsel Conference Call Participants Paul Cooney - Joseph Gunnar Aaron Grey - Alliance Global Partners Scott Fortune - Roth Capital Partners Gerald Pascarelli - Cowen Operator Good afternoon. And welcome to the cbdMD Third Quarter Fiscal 2020 Earnings Call and Update. Th ...